When was Mobidiag founded?

Mobidiag was founded in 2000 and raised its 1st funding round 17 years after it was founded.

Where is Mobidiag located?

Mobidiag is headquartered in Espoo, Finland.

How many employees does Mobidiag have?

As of Mar 01, 2026, the latest employee count at Mobidiag is 50 - 199.

Is Mobidiag a funded company?

Mobidiag is a funded company, having raised a total of $16.1M across 7 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Apr 18, 2017.

When was the latest funding round of Mobidiag?

Mobidiag's latest funding was a $***** Conventional Debt round on Jan 07, 2020, with participation from 0 investor.

What is the annual revenue of Mobidiag?

Annual revenue of Mobidiag is between €10M and €50M as on Sep 30, 2023

Where does Mobidiag rank among its competitors?

Mobidiag ranks 5th amongst 20 active competitors, of which 9 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Pensievision, which secured $1M in Oct, 2025.

Who are the top competitors of Mobidiag?

Mobidiag's top competitors include Teal Health, MobileODT and Guided Therapeutics. Among them, Pensievision secured the most recent funding round in October, 2025.

Mobidiag - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Mobidiag an acquired company?

Mobidiag got acquired by Hologic on Apr 08, 2021.

Mobidiag is an acquired company based in Espoo (Finland), founded in 2000 by Mart Saarma. It operates as an In vitro diagnostics for infectious diseases. Mobidiag has raised $16.1M in funding from Autobio and Springvest. The company has 20 active competitors, including 9 funded and 4 that have exited. Its top competitors include companies like Teal Health, MobileODT and Guided Therapeutics.

Company Details

Mobidiag develops and provides rapid and easy-to-use solutions for in vitro diagnostics of infectious diseases. Its Amplidiag product line uses multiplex PCR for gastrointestinal infections. These kits include tests for H. pylori, CarbaR+VRE, C. difficile, and blanket tests for stool parasites, bacterial and viral infections. It also has the Amplidiag Easy and Novodiag instruments for rapid diagnostics, and the Prove-it range of test kits for bone, joint, and herpes diagnostics.

Website: www.mobidiag.com
Social
Email ID: *****@mobidiag.com

Key Metrics

Founded Year

2000

Location

Espoo, Finland

Stage

Acquired

Total Funding

$16.1M in 7 rounds

Latest Funding Round

Conventional Debt, Jan 07, 2020, $*****

Investors

Autobio & 4 more

Ranked

5^th among 20 active competitors

Annual Revenue

€10M - €50M as on Sep 30, 2023

Employee Count

50 - 199 as on Mar 01, 2026

Similar Companies

Teal Health & 19 more

Exit Details

Acquired by Hologic (Apr 08, 2021)

View Mobidiag's full profile

Mobidiag is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Mobidiag Oy CIN: 1651007-2 , Finland, Active	Jul 25, 2000	€10M - €50M (As on Sep 30, 2023)	-	-

Mobidiag got acquired by Hologic on Apr 08, 2021 at an acquisition amount of $*****.

Click here to take a look at Mobidiag's acquisition in detail

Mobidiag has raised a total funding of $16.1M over 7 rounds. Its first funding round was on Apr 18, 2017. Mobidiag has 5 institutional investors.

Here is the list of recent funding rounds of Mobidiag:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 07, 2020	7503929	Conventional Debt	9625716	3749477	2455758	4464745
May 14, 2019	7521728	Conventional Debt	7262553	8134641	2508856	European Investment Bank
Feb 04, 2019	7493171	Series B	2227714	5534160	Autobio	6614155

Access funding benchmarks and valuations. Sign up today!

View details of Mobidiag's funding rounds and investors

The founders of Mobidiag is Mart Saarma.

Here are the details of Mobidiag's key team members:

Mart Saarma: Founder of Mobidiag.

View details of Mobidiag's Founder profiles and Board Members

Mobidiag's employee count trend

Mobidiag has 50 - 199 employees as of Mar 26. Here is Mobidiag's employee count trend over the years:

Uncover Mobidiag's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Mobidiag include Teal Health, MobileODT and Guided Therapeutics. Here is the list of Top 10 competitors of Mobidiag, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Teal Health 2020, San Francisco (United States), Seed	Provider of at-home cervical cancer screening kit and consultation	$23M	Emerson Collective, Forerunner Ventures & 9 others	56/100
2nd	MobileODT 2012, Tel Aviv (Israel), Acquired	Provider of AI-based diagnostic tools for the screening of cervical cancer	$26M	Orbimed, CE Ventures & 16 others	53/100
3rd	Guided Therapeutics 1992, Norcross (United States), Public	Developer of light-based diagnostic and prognostic devices for cervical cancer	-	Rosalind Advisors, National Cancer Institute ... & 5 others	52/100
4th	TruScreen 1980, Sydney (Australia), Public	Cervical cancer screening device	-	-	46/100
5th	Mobidiag 2000, Espoo (Finland), Acquired	In vitro diagnostics for infectious diseases	$16.1M	European Investment Bank, Lynx Financial & 3 others	44/100
6th	Illumigyn 2014, Jerusalem (Israel), Series B	Developer of colonoscope for cervical cancer detection interventional procedures	$38M	Yozma, ATU Partners & 3 others	42/100
7th	Pragmatech Healthcare Solutions 2019, Vadodara (India), Seed	Developer of a screening device for the detection of cervical cancer	$131K	Pfizer, Entrepreneurship Development Institute of India ... & 7 others	37/100
8th	DySIS Medical 2002, Livingston (United Kingdom), Series B	Device for early detection, diagnosis, and monitoring of cancerous and pre-cancerous lesions of the cervix	$36.3M	Lundbeck Foundation, South Indian Bank & 7 others	36/100
9th	Hera Diagnostics 2020, Mcallen (United States), Seed	Developer of cervical cancer screening device	$898K	-	35/100
10th	Pensievision 2015, San Diego (United States), Seed	Innovative 3D medical imaging technology for healthcare and industrial applications	$100K	Luminate, HHS	35/100